Where does Roche Innovation Center Copenhagen A/S rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Roche Innovation Center Copenhagen A/S ranks #7,069 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Roche Innovation Center Copenhagen A/S hold?

Roche Innovation Center Copenhagen A/S holds 47 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is Roche Innovation Center Copenhagen A/S's Innovation Score?

Roche Innovation Center Copenhagen A/S has an Innovation Score of 48.0 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Roche Innovation Center Copenhagen A/S's patent grant rate increasing or decreasing?

Roche Innovation Center Copenhagen A/S's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Roche Innovation Center Copenhagen A/S's patents?

Roche Innovation Center Copenhagen A/S's patents average 22.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Roche Innovation Center Copenhagen A/S patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Roche Innovation Center Copenhagen A/S

Q: What technology areas does Roche Innovation Center Copenhagen A/S focus on?

Roche Innovation Center Copenhagen A/S's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 38 patents, ranking #278 of 4,144 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 47 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Roche ranks #7,069 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 15 technology areas.

#7,069
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.0/100): 22.7
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7069 · Foreign Corporation #7,069 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,069/49,997
PHOTO-FINISH Pivot Medical
CPC-FOCUS C12N · 15 areas
INNOV-PAR 48.0/100
CLAIMS-DENSE 22.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pivot Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Roche’s 48.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (28%) Velocity 7.3 pts (15%) Breadth 13.7 pts (29%) Claim depth 13.6 pts (28%)

Qualcomm Incorporated · highest

85
Dwango · near

48
IHC Holland IE B V · near

48
Longyear TM · near

48
Pcms Holdings · near

48
Roche Innovation… · this assignee

48
3D Lighting… · lowest

7

What this shows Roche's Innovation Score is 48.0/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Roche?

Each dot is one of Roche’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Roche’s own 22.7 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Roche vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Roche's grants concentrate

Roche Innovation Center Copenhagen A/S is a focused PatentsView assignee: 15 CPC subclasses with 80.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2024. By volume, Roche sits between Pivot Medical, Inc. and Sanhua (HANGZHOU) Micro Channel Heat Exchanger Co., Ltd..

Roche's three-year grant acceleration

Roche Innovation Center Copenhagen A/S shows 12 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pivot Medical

47
Qualys

47
Repsol

47
Rion

47
Rodenstock

47
Racing Optics

47
Samsung EletrÔNIC…

47
Sanhua (Hangzhou)…

47
Roche Innovation… ◀

47

What this shows Roche holds 47 patents at rank #7,067, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roche

By rank, the assignees closest to #7,067 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Roche's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Roche ranks #278 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Longyear TM, Inc. 48 IHC Holland IE B.V. 48 Pcms Holdings, Inc. 48 Dwango Co., Ltd. 48

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Roche Innovation Center Copenhagen A/S patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	6.4%
2016	5	10.6%
2017	5	10.6%
2018	6	12.8%
2019	5	10.6%
2020	2	4.3%
2021	4	8.5%
2022	3	6.4%
2023	8	17.0%
2024	1	2.1%
2025partial year	5	10.6%

Which technologies does Roche Innovation Center Copenhagen A/S patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 30

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 23

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 18

Y02A - Technologies FOR Adaptation TO Climate Change 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C12Y - Enzymes 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A61B - DIAGNOSIS; SURGERY; Identification 1

C07K - Peptides 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Roche Innovation Center Copenhagen A/S's patent record in context - here's where to go next.

Roche Innovation Center Copenhagen A/S's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 80.9% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #7,069 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Roche Innovation Center Copenhagen A/S against Pivot Medical, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.